Hong Kong and Macau on Wednesday said they were suspending the use of Pfizer/BioNTech’s coronavirus vaccine after being informed of a packaging problem with a batch of vials.

“For the sake of precaution, the current vaccination must be suspended during the period of investigation,” Hong Kong’s government said in a statement.

Both Chinese cities said their decision came after they were contacted about the issue by Fosun, the Chinese pharmaceutical company that is distributing the Pfizer/BioNTech vaccine in China.

Vials with the lot number 210102 were found to have defective packaging, authorities said.

The statements from Hong Kong and Macau did not give any details on how the packaging was defective but both said they did not believe there were any safety risks.

Authorities said they decided to act out of an abundance of caution until their investigation is concluded.

Some Hong Kongers took to social media to say their appointments that day had been cancelled and that some vaccination centres were closed.

One centre visited by an AFP reporter had been taped off.

– AFP

Subscribe
Notify of
7 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

MCCs and TPAs to be regulated under Private Hospitals and Medical Clinics Act (PHMCA)

Minister of State for Health Chee Hong Tat said that managed care…

Thailand virus cases soar with prison clusters

Thailand reported a new daily high of nearly 10,000 coronavirus cases on…

181 new cases of COVID-19 infection in S’pore; 179 locally transmitted cases, 130 linked to Jurong Fishery Port cluster and 8 belong to KTV cluster

As of Wednesday noon (21 July), the Ministry of Health (MOH) has…